All In Biotech

Drug Trial Radar · NCT02456038

Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)

A Multicenter Study of the Safety and Efficacy of Asfotase Alfa (ALXN1215) (Human Recombinant Tissue Nonspecific Alkaline Phosphatase Fusion Protein) in Patients With Hypophosphatasia (HPP)

Last checked: Nov 20, 2026Latest source record: Mar 31, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

13

Actual

Start

Aug 2014

Primary completion

Jul 2015

Study completion Jul 2015

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Osaka University Graduate School of Medicine
First posted
May 28, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this study is to assess safety and efficacy of Asfotase Alfa (ALXN1215) in patients with hypophosphatasia

Conditions

  • Hypophosphatasia

Interventions

  • Asfotase Alfa (ALXN1215)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of subjects with Adverse Events as an assessment of the Safety of repeated subcutaneous (SC) injections of asfotase alfaTime frame: Up to 50 months or until regulatory approval

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Kurume University Hospital

    Kurume, Fukuoka, Japan

  • National Hospital Organization Nagara Medical Center

    Gifu, Gifu, Japan

  • Hiroshima University Hospital

    Hiroshima, Hiroshima, Japan

  • Hokkaido University Hospital

    Sapporo, Hokkaido-prefecture, Japan

  • Tohoku University Hospital

    Sendai, Miyagi, Japan

  • Niigata University Medical & Dental Hospital

    Niigata, Niigata, Japan

  • Osaka Medical Center and Research Institute for Maternal and Child Health

    Izumi, Osaka, Japan

  • Osaka University Hospital

    Suita, Osaka, Japan

  • Saitama Children's Medical Center

    Saitama, Saitama, Japan

  • Hamamatsu University Hospital

    Hamamatsu, Shizuoka, Japan

  • Nippon Medical School Hospital

    Bunkyo-ku, Tokyo, Japan

  • Showa General Hospital

    Kodaira, Tokyo, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.